Showing results (1191-1200 of 3,081) with videos related to

Sort By:
Pageof 309
Drug Safety|October 30, 2014
Causality assessment for suspected DILI during clinical phases of drug developmentArie Regev, Leonard B Seeff, Michael Merz, et al.
Drug Safety|November 16, 2014
A description of signals during the first 18 months of the EMA pharmacovigilance risk assessment committeeAlexandra C Pacurariu, Preciosa M Coloma, Anja van Haren, et al.
Drug Safety|March 30, 2000
Assessing the safety of drugs in pregnancy: the role of prospective cohort studiesC Irl, J Hasford
Drug Safety|March 30, 2000
A risk-benefit analysis of methadone maintenance treatmentJ Bell, D Zador
Drug Safety|March 30, 2000
Drug-induced aseptic meningitis: diagnosis and managementS Jolles, W A Sewell, C Leighton
Drug Safety|March 30, 2000
Trimethoprim-induced hyperkalaemia: clinical data, mechanism, prevention and managementM A Perazella
Drug Safety|March 30, 2000
Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and managementD Jaspersen
Drug Safety|February 24, 2001
Anticancer drug-induced kidney disordersP E Kintzel
Drug Safety|March 10, 2001
Thalomid (Thalidomide) capsules: a review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribingT E Clark, N Edom, J Larson, et al.
Drug Safety|August 17, 2000
A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the kneeM E Adams, A J Lussier, J G Peyron
Pageof 309